JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franzius, C.
Right arrow Articles by Schober, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franzius, C.
Right arrow Articles by Schober, O.

Prognostic Significance of 18F-FDG and 99mTc-Methylene Diphosphonate Uptake in Primary Osteosarcoma

Christiane Franzius, MD1, Stefan Bielack, MD2, Silke Flege2, Joachim Sciuk, MD1, Heribert Jürgens, MD2 and Otmar Schober, MD, PhD1

1 Department of Nuclear Medicine, Münster University Hospital, Münster, Germany
2 Department of Pediatric Hematology and Oncology, Münster University Hospital, Münster, Germany



View larger version (16K):

[in a new window]
 
FIGURE 1. Disease outcome for whole patient group as determined by Kaplan-Meier analyses using overall survival (A) and event-free survival (B). Tick marks indicate individual follow-up period.

 


View larger version (37K):

[in a new window]
 
FIGURE 2. Disease outcome for 99mTc-MDP T/NTmax (overall survival [A] and event-free survival [B]) and 18F-FDG T/NTmax (overall survival [C] and event-free survival [D]) as determined by Kaplan-Meier analyses. Median levels were used as cutoff values. Tick marks indicate individual follow-up period.

 


View larger version (18K):

[in a new window]
 
FIGURE 3. Relationship between various 18F-FDG T/NTmax cutoff values and their discriminative value for both overall survival (A) and event-free survival (B) as assessed by log-rank test. Broad range of 18F-FDG T/NTmax ratios gave significant log-rank probability values (P < 0.05).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.